Observational Study for the Evaluation of Clinical Effectiveness in Routine Practice of Daxas (Roflumilast), in Approximately 2700 Patients With Severe and Very Severe COPD (Chronic Obstructive Pulmonary Disease) in Greece

Trial Profile

Observational Study for the Evaluation of Clinical Effectiveness in Routine Practice of Daxas (Roflumilast), in Approximately 2700 Patients With Severe and Very Severe COPD (Chronic Obstructive Pulmonary Disease) in Greece

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Dec 2016

At a glance

  • Drugs Roflumilast (Primary)
  • Indications Chronic bronchitis; Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors AstraZeneca; Takeda
  • Most Recent Events

    • 14 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top